The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
TGF‐β1 targets Smad, p38 MAPK, and PI 3K/Akt signaling pathways to induce PFKFB 3 gene expression and glycolysis in glioblastoma cells
Abstract
In human cancers, transforming growth factor‐β1 (TGF‐β1) plays a dual role by acting as both a tumor suppressor and a promoter of tumor metastasis. Although TGF‐β1 contributes to the metabolic reprogramming of cancer cells and tumor‐associated stromal cells, little is known of the molecular mechanisms connecting this cytokine with enhanced glycolysis. PFKFB 3 is a homodymeric bifunctional enzyme, belonging to the family of 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatases, that controls the conversion of fructose‐6‐phosphate (Fru‐6‐P) to fructose‐2,6‐bisphosphate (Fru‐2,6‐P 2). This metabolite is important for the dynamic regulation of glycolytic flux by allosterically activating phosphofructokinase‐1, a rate‐limiting enzyme in glycolysis. The PFKFB 3 gene is involved in cell proliferation via its role in carbohydrate metabolism. Here, we studied the mechanisms connecting TGF‐β1, glucose metabolism, and PFKFB 3 in glioblastoma cell lines. We demonstrate that TGF‐β1 upregulates PFKFB 3 mRNA and protein expression resulting in an increase in fructose 2,6‐bisphosphate concentration, glucose uptake, glycolytic flux and lactate production. Moreover, these increases in PFKFB 3 mRNA and protein expression and Fru‐2,6‐P 2 concentration were reduced when the Smad3, p38 mitogen‐activated protein kinase (MAPK), and phosphoinositide 3‐kinase (PI 3K)/Akt signaling pathways were inhibited. We demonstrate that inhibition of PFKFB 3 activity with 3 PO or si RNA‐mediated knockdown of PFKFB 3 significantly eliminated the capacity of the T98G cells to form colonies by TGF‐β1, one of the hallmarks of transformation. Taken together, these results show that TGF‐β1 induces PFKFB 3 expression through activation of the p38 MAPK and PI 3K/Akt signaling pathways that complement and converge with early activation of Smad signaling. This suggests that PFKFB 3 induction by TGF‐β1 can be one of the main mechanisms mediating the reprogramming of glioma cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Horowitz, J. C., Lee, D. Y., Waghray, M., Keshamouni, V. G., Thomas, P. E., Zhang, H., Cui, Z., & Thannickal, V. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306248200 · Cited by 239
Transforming Growth Factor (TGF)-β Promotes de Novo Serine Synthesis for Collagen Production
Nigdelioglu, R., Hamanaka, R. B., Meliton, A. Y., O'Leary, E., Witt, L. J., Cho, T., Sun, K., Bonham, C., Wu, D., Woods, P. S., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.756247 · Cited by 169
Glycolysis and methylaminoisobutyrate uptake in rat-1 cells transfected with ras or myc oncogenes.
Racker, E., Resnick, R. J., & Feldman, R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.11.3535 · Cited by 135
Ruiz-García, A., Monsalve, E., Novellasdemunt, L., Navarro-Sabaté, À., Manzano, A., Rivero, S., Castrillo, A., Casado, M., Laborda, J., Bartrons, R., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190298 · Cited by 95
Self-citation
Cited by
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Endothelial to Mesenchymal Transition in Cardiovascular Disease
Kovacic, J. C., Dimmeler, S., Harvey, R. P., Finkel, T., Aikawa, E., Krenning, G., & Baker, A. H. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.089 · Cited by 631
The Warburg Effect 97 Years after Its Discovery
Pascale, R. M., Calvisi, D. F., Simile, M. M., Feo, C. F., & Feo, F. (2020) · Cancers · doi:10.3390/cancers12102819 · Cited by 300
TGF-β signaling in the tumor metabolic microenvironment and targeted therapies
Shi, X., Yang, J., Deng, S., Xu, H., Wu, D., Zeng, Q., Wang, S., Hu, T., Wu, F., & Zhou, H. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01349-6 · Cited by 262
Piers, T. M., Cosker, K., Mallach, A., Johnson, G. T., Guerreiro, R., Hardy, J., & Pocock, J. M. (2020) · The FASEB Journal · doi:10.1096/fj.201902447r · Cited by 135
Metadata
- Authors
- Rodríguez‐García, A., Samsó, P., Fontova, P., Simon‐Molas, H., Manzano, A., Castaño, E., Rosa, J. L., Martinez‐Outshoorn, U., Ventura, F., Navarro‐Sabaté, À., & Bartrons, R.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2017-09-10
- Volume
- 284
- Issue
- 20
- Pages
- 3437-3454
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W2746191482
- Cited by
- 174
- References
- 5
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.